You are offline. Saved alerts are still available. Live updates resume when you reconnect.
Reading a stock page
- The tabs show the price chart, results, shareholding, events and news for this one company.
- The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
- Every figure names its source. "Official" means it came from NSE or BSE filings.
- Use the star to watch the stock, or Add to portfolio to record a trade.
🎯 Buy It or Not? — Complete Intraday to Long-Term Decision Report for ASTERDM (NSE)
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
66
ISA Signal Score: Positive
Trend70
Momentum70
52-week range61
Volume82
Risk69
Fundamentals50
Working for it
- Price is above its 20-day average
- Price is above its 50-day average
- Price is above its 200-day average (long-term uptrend)
- RSI 59: healthy strength
- More volume on up days than down days (accumulation)
- Revenue grew 12% year on year
Working against it
- 50-day average is below the 200-day average
- 50-day average is falling
- Profit fell 92% year on year
Red flags
- Profit fell sharply (92%)
At a glance
QualityAverageROE 11.8%, ROCE 11.5%, debt 0.62x equity
GrowthSlowSales -18.0%, profit -8.2% a year over 4 years
ValuationExpensiveP/E 98.7 vs sector median 42.8
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 13.6 points
RiskMediumSwings 29% a year, fell up to 26% from a peak, beta 0.42
Smart Investor Tips: ASTERDM
Balanced / Watch for Key Level ConfirmationActionable Insights & Positives
- Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.
Risk Checks & Things to Verify
- Premium valuation: P/E of 98.7x vs sector median 42.8x leaves less margin of safety if growth slows.
NSE MCP Live & 5-Year Check No API Key
Algorithmic Momentum Prediction & Optimal Entry PriceHOLD / POSITIVE ON SUPPORT (Score 49/100)
Consolidating. If buying, accumulate only on dips into support at Rs 704.28 – Rs 731.91 (Ideal ~Rs 718.10). Review if price closes below Rs 666.19; upside resistance near Rs 811.54.
| Optimal Support area | Tranche 1 (50%) | Tranche 2 (50%) | Risk level / Review | Level 1 (Swing) | Level 2 (Breakout) | Risk : Reward |
|---|---|---|---|---|---|---|
| Rs 704.28 – Rs 731.91 Ideal ~Rs 718.10 |
Rs 731.91 | Rs 704.28 | Rs 666.19 ATR 3.4% |
Rs 811.54 | Rs 891.30 | 1 : 1.8 RSI 68 · Vol 2.23x |
Live Candlestick & TradingView Chart (ASTERDM)
MARKET CLOSED - EOD SNAPSHOTKey figures
P/E98.7sector median 42.8
P/B-price / book value
EPSRs 7.49grew -8.2% a year
Dividend yield-from saved dividend events
Debt to equity0.62xnet debt Rs 2,594 Cr
Sales growth-18.0%a year over 4 years
Profit growth-8.2%a year over 4 years
Operating margin18.8%net margin 9.2%
Company Debt, Borrowings & Cash Flow Health
Total Debt / Loans
Rs 2,594 Cr
Increased +Rs 202 Cr YoY
Cash & Bank Balances
-
Liquid cash & equivalents
Net Debt (Loans − Cash)
Rs 2,594 Cr
32.1% of total assets
Debt to Equity & Interest Cover
0.62x D/E
Interest cover: 5.3x EBIT
Operating Cash Flow (OCF)
Rs 656 Cr
OCF/PAT conversion: 154%
Free Cash Flow (FCF)
-
OCF minus Capex
About ASTER DM QUALITY CARE
Market capNot available
First listed26 Feb 2018BSE not available · NSE 26 Feb 2018
Face valueRs 10
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed
Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE
Shareholding
Promoters and group 53.79% +0.07 pp, public 46.10%, as on 30 Sep 2026. Holder names and history
Day range727.00 to 740.45Open 734.00
52-week high891.30
-17.1% from high (10 Aug 2026)
52-week low519.10
+42.4% from low (04 Feb 2026)
Volume3.74 L
0.4x the 20-day average
RSI (14)59
neutral
Volatility (30d)31.6%annualised
Returns
1W+0.5%
1M+10.8%
3M-3.4%
6M-2.6%
1Y+11.6%
YTD+19.9%
3Y a year+28.4%
5Y a year+30.4%
Against the NIFTY 50
| Period | ASTERDM | NIFTY 50 | Difference |
|---|---|---|---|
| 1M | +10.8% | +11.5% | -0.7 pts |
| 3M | -3.4% | +5.3% | -8.7 pts |
| 6M | -2.6% | +7.9% | -10.5 pts |
| 1Y | +11.6% | -2.1% | +13.6 pts |
Risk over the past year
Volatility29%medium
Deepest fall-25.9%from a peak
Beta0.42moves less than the index
Best day+6.2%04 May 2026
Worst day-5.0%30 Sep 2026
Up days50%of sessions
🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition
Piotroski F-Score: 5 / 9 · Solid Financial Health
3-Step DuPont ROE Identity:
Balanced Profitability & Efficiency
Net Margin: 9.2%
×
Asset Turnover: 0.57x
×
Equity Multiplier: 1.92x
=
ROE 11.8%
✓ Positive Net Profit (PAT > 0)
Rs 427 Cr
✓ Positive Operating Cash Flow (OCF > 0)
Rs 656 Cr
✓ High Cash Conversion (OCF >= 85% of PAT)
154% conversion
⚠ Improving Return on Assets (ROA YoY)
5.3% vs 81.9%
✓ Conservative / Decreasing Debt-to-Equity
0.62x (prev 0.78x)
✓ Healthy Balance Sheet Asset Coverage
6.31x
⚠ Institutional Return on Equity (ROE >= 14%)
11.8%
⚠ Stable / Expanding Profit Margin YoY
9.2% vs 130.7%
⚠ Asset Turnover Efficiency (Sales / Assets)
0.57x
Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration)
| Rs crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales / Revenue | 576 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 | 2,829 |
| Sales QoQ % | -4.7% | +73.5% | +7.8% | +11.0% | -0.9% | -0.3% | +10.9% | +115.8% |
| Operating Profit | 88.1 | 182 | 201 | 236 | 202 | 223 | 255 | 655 |
| Operating Margin (OPM %) | 15.3% | 18.2% | 18.6% | 19.7% | 17.0% | 18.9% | 19.5% | 23.2% |
| Net Profit (PAT) | 49.8 | 86.0 | 94.0 | 121 | 59.0 | 154 | 29.0 | 322 |
| Profit QoQ % | -44.5% | +72.6% | +9.3% | +28.7% | -51.2% | +161.0% | -81.2% | +1010.3% |
| Profit YoY % | -6.3% | +1160.4% | -98.4% | +34.7% | +18.4% | +79.1% | -69.1% | +166.1% |
| Net Margin % | 8.6% | 8.6% | 8.7% | 10.1% | 5.0% | 13.0% | 2.2% | 11.4% |
Sales and profit
Sales growth-18.0%a year, 4Y
Profit growth-8.2%a year, 4Y
EPS growth-8.2%a year, 4Y
Avg ROE36.8%5 years
Profit and loss
| Rs crore | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales | 10,253 | 11,933 | 3,699 | 4,138 | 4,643 |
| Sales growth | - | +16.4% | -69.0% | +11.9% | +12.2% |
| Operating profit | 1,534 | 1,565 | 578 | 756 | 875 |
| Operating margin | 15.0% | 13.1% | 15.6% | 18.3% | 18.8% |
| Other income | 51.0 | 78.3 | 24.9 | 5,168 | 91.0 |
| Interest | 307 | 329 | 110 | 133 | 132 |
| Depreciation | 641 | 780 | 220 | 249 | 264 |
| Profit before tax | 637 | 534 | 273 | 5,542 | 570 |
| Tax rate | 6.0% | 11.2% | 20.7% | 2.0% | 25.0% |
| Net profit | 601 | 425 | 129 | 5,408 | 427 |
| Profit growth | - | -29.3% | -69.6% | +4083.2% | -92.1% |
| Net margin | 5.9% | 3.6% | 3.5% | 130.7% | 9.2% |
| EPS (Rs) | 10.53 | 8.55 | 2.60 | 107.66 | 7.49 |
Balance sheet
| Rs crore | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity (net worth) | 3,580 | 4,448 | 4,560 | 3,054 | 4,201 |
| Borrowings | 5,282 | 2,287 | 669 | 2,392 | 2,594 |
| Cash | - | 429 | 113 | - | - |
| Total assets | 12,521 | 14,881 | 17,991 | 6,600 | 8,076 |
| Debt to equity | 1.48x | 0.51x | 0.15x | 0.78x | 0.62x |
Debt, Loans, Cash Flow & Working Capital
| Rs crore | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash Flow (OCF) | 1,314 | 1,834 | 158 | 425 | 656 |
| Capital Expenditure (Capex) | - | 717 | 797 | - | - |
| Free Cash Flow (FCF = OCF - Capex) | - | 1,117 | -639 | - | - |
| OCF / Net Profit Conversion | 2.19x | 4.32x | 1.22x | 0.08x | 1.54x |
| Total Borrowings / Loans | 5,282 | 2,287 | 669 | 2,392 | 2,594 |
| Cash & Bank Balances | - | 429 | 113 | - | - |
| Trade Receivables (Cr) | - | 2,336 | 233 | - | - |
| Receivable Days | - | 71.46x | 23.03x | - | - |
| Inventories (Cr) | - | 1,306 | 111 | - | - |
| Inventory Days | - | 39.94x | 10.91x | - | - |
Returns on capital
| Rs crore | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE | 16.8% | 10.6% | 2.9% | 142.1% | 11.8% |
| ROCE | 10.7% | 9.0% | 2.8% | 50.3% | 11.5% |
| Interest cover | 3.07x | 2.62x | 3.47x | 42.67x | 5.32x |
Compared with its sector Pharma & Healthcare
| Stock | Price | Day | 1 year | Mkt cap (Cr) | P/E | P/B | ROE | Net margin |
|---|---|---|---|---|---|---|---|---|
| ALIVUSALIVUS LIFE SCIENCES LTD | 1,449.90 | +0.4% | - | 17,769 | 37.7 | 7.6 | 20.2% | 20.6% |
| CAPLIPOINTCAPLIN POINT LAB LTD. | 2,084.60 | -0.0% | - | 15,833 | 34.6 | 6.8 | 19.7% | 27.0% |
| AARTIPHARMAARTI PHARMALABS LIMITED | 1,024.60 | +1.1% | - | 9,285 | 42.8 | 5.3 | 12.3% | 11.7% |
| BLUEJETBLUE JET HEALTHCARE LTD | 516.85 | -0.3% | - | 8,965 | 54.8 | 10.6 | 19.4% | 23.0% |
| AARTIDRUGSAARTI DRUGS LTD. | 498.90 | -1.4% | - | 4,587 | 26.9 | 3.6 | 13.4% | 6.8% |
| DIVISLABDIVI S LABORATORIES LTD | 11,178.00 | +1.2% | - | - | 115.6 | - | 15.3% | 24.3% |
| WOCKPHARMAWOCKHARDT LIMITED | 2,187.00 | +7.9% | - | - | - | - | - | - |
| LAURUSLABSLAURUS LABS LIMITED | 2,306.00 | -0.7% | - | - | - | - | - | - |
| SUNPHARMASUN PHARMACEUTICAL IND L | 1,900.00 | +1.5% | - | - | - | - | - | - |
| MAXHEALTHMAX HEALTHCARE INS LTD | 1,040.65 | +1.7% | - | - | - | - | - | - |
| CIPLACIPLA LTD | 1,418.50 | +0.1% | - | - | 29.5 | - | - | 13.7% |
| APOLLOHOSPAPOLLO HOSPITALS ENTER. L | 8,738.00 | -0.9% | - | - | 64.7 | - | 21.1% | 7.9% |
| ASTERDMASTER DM QUALITY CARE LTD | 739.30 | +1.1% | - | - | 98.7 | - | 10.2% | 9.2% |
| Sector median | - | 42.8 | 6.8 | 13.4% |
Today: 15 minute chart and signal
Analysis and next-session reading
Signals
Price is above its 50-day average
20-day average is below the 50-day (short-term downtrend)
Price is above its 200-day average (long-term uptrend)
RSI 59: neutral
When is a good price?
The price is in the upper half of its 1-year range and is lower than it was on 38% of days in the past year.
Support (prices below today's)
| 200-day average | 722.45 | -2.3% |
| 50-day average | 715.00 | -3.3% |
| 20-day low | 638.00 | -13.7% |
| 60-day low | 638.00 | -13.7% |
| 52-week low | 519.10 | -29.8% |
Resistance (prices above today's)
| 20-day high | 757.45 | +2.5% |
| 60-day high | 798.80 | +8.0% |
| 52-week high | 891.30 | +20.6% |
Zones buyers often watch
| Lower quarter of the 1-year range | 519.10 to 612.15 | Historically the cheapest part of the past year. |
| Pullback of 10% to 20% from the high | 713.04 to 802.17 | price is inside this zone now |
| Around the 200-day average | 700.78 to 744.12 | price is inside this zone now |
Moving averages and momentum
| Indicator | Value | Reading |
|---|---|---|
| 20-day average | 701.04 | Price is 5.5% above |
| 50-day average | 715.00 | Price is 3.4% above |
| 200-day average | 722.45 | Price is 2.3% above |
| RSI (14) | 59 | Neutral |
| MACD (12, 26, 9) | 10.62 | Above its signal line (momentum rising) |
| Volatility (30d) | 31.6% | Medium yearly swings |
Support and resistance
R2749.03
R1744.17
Pivot735.58
S1730.72
S2722.13
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| 2026-11-19 | 734.00 | 740.45 | 727.00 | 739.30 | +1.14% | 373,933 |
| 2026-11-18 | 739.40 | 750.60 | 728.00 | 731.00 | -0.94% | 865,980 |
| 2026-11-17 | 750.30 | 756.25 | 732.45 | 737.95 | -1.61% | 944,649 |
| 2026-11-16 | 723.35 | 757.45 | 722.70 | 750.00 | +3.81% | 1,480,204 |
| 2026-11-13 | 735.90 | 740.00 | 718.60 | 722.50 | -1.82% | 1,056,881 |
| 2026-11-12 | 724.20 | 739.30 | 715.20 | 735.90 | +1.62% | 929,758 |
| 2026-11-11 | 744.70 | 744.70 | 717.00 | 724.20 | -1.27% | 1,250,632 |
| 2026-11-09 | 733.60 | 746.65 | 703.60 | 733.50 | -2.12% | 2,061,487 |
| 2026-11-06 | 720.00 | 722.15 | 702.50 | 713.15 | -0.89% | 1,163,127 |
| 2026-11-05 | 729.90 | 729.90 | 710.65 | 719.55 | +0.00% | 2,153,629 |
| 2026-11-04 | 683.80 | 729.00 | 679.05 | 719.55 | +5.61% | 1,782,568 |
| 2026-11-03 | 676.55 | 688.50 | 676.55 | 681.35 | +1.11% | 364,213 |
| 2026-11-02 | 686.50 | 690.75 | 672.00 | 673.85 | -1.07% | 367,329 |
| 2026-10-30 | 677.50 | 690.95 | 668.70 | 681.15 | +0.29% | 1,151,062 |
| 2026-10-29 | 672.00 | 683.00 | 669.00 | 679.20 | +1.46% | 461,603 |
| 2026-10-28 | 660.00 | 678.15 | 652.40 | 669.45 | +1.00% | 354,579 |
| 2026-10-27 | 653.30 | 673.90 | 650.00 | 662.80 | +2.44% | 693,678 |
| 2026-10-26 | 644.50 | 656.25 | 638.75 | 647.00 | +0.35% | 1,679,705 |
| 2026-10-23 | 654.05 | 659.70 | 638.00 | 644.75 | -1.52% | 645,624 |
| 2026-10-22 | 650.05 | 656.55 | 641.80 | 654.70 | +0.70% | 523,658 |
| 2026-10-21 | 674.50 | 676.80 | 648.70 | 650.15 | -2.55% | 928,509 |
| 2026-10-19 | 674.40 | 684.85 | 664.80 | 667.15 | -1.07% | 413,105 |